Viatris(VTRS) Prnewswire·2025-04-28 09:45Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Viatris Inc. regarding a class action lawsuit related to misleading statements about the company's Indore, India facility inspection and its subsequent financial performance [1][2]. Summary by Relevant Sections Allegations - The complaint alleges that Viatris' management misrepresented the significance of a warning letter from the FDA concerning the Indore facility, downplaying it as a "minor headwind" [1]. - Following the announcement of disappointing financial results for Q4 and fiscal year 2024, Viatris attributed its below-expectation guidance to the financial impact of the warning letter and import alert [1]. Financial Impact - On February 27, 2025, Viatris' stock price dropped from 9.53 per share, marking a decline of approximately 15.21% in one day [1]. Class Action Details - Shareholders who purchased shares during the class period from August 8, 2024, to February 26, 2025, are encouraged to register for the class action, with a deadline of June 3, 2025, to seek lead plaintiff status [2]. - Participants will be enrolled in a portfolio monitoring system to receive updates on the case [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3].